Oncolytics Biotech (ONCY) Soars: Stock Up 6.3% - Tale of the Tape
24 Janvier 2014 - 2:51PM
Zacks
Oncolytics Biotech
Inc. (ONCY) was a big mover last session, as its shares
rose over 6% on the day. The rise came on solid volume too with far
more shares changing hands than in a normal session. This breaks
the recent uptrend for the company, as the stock is now trading
above the volatile price range of $1.54 to $1.81 in the past
one-month timeframe.
In the last 30 days, the company did not witness any estimate
revision and the Zacks Consensus Estimate also remained unchanged.
Yesterday’s price action is encouraging though, so make sure to
keep a close watch on this firm in the near future.
Oncolytics currently has a Zacks Rank #3 (Hold) while its Earnings
ESP is 0.00%.
Other better-ranked stocks in the medical sector include
Gentium S.p.A (GENT), Emergent
BioSolutions, Inc. (EBS) and Actelion
Ltd. (ALIOF). All three sport a Zacks Rank #1 (Strong
Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
EMERGENT BIOSOL (EBS): Free Stock Analysis Report
GENTIUM SPA-ADR (GENT): Free Stock Analysis Report
ONCOLYTICS BIO (ONCY): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
(USOTC:ALIOF)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
(USOTC:ALIOF)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about (OTCMarkets): 0 recent articles
Plus d'articles sur Actelion Ltd. (PC)